XB-371

N/A

Report date: 2025/08/15 20:01:28

Base Information

Drug NameXB-371
Drug Alias NameXB-371XB371
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDNA topoisomerase inhibitorsTissue factor inhibitors
TargetsDNA topoisomeraseTissue factor
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCatalent IncExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesExelixis Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A